31/08/2015 18:42:48 Cookie Policy Free Membership Login

Allergy Thera. Share Chat - AGY

Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change Price Change % Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.25 +1.00% 25.25 24.50 26.00 25.25 25.00 25.00 83,451 08:27:34
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 42.0 1.1 0.2 157.8 137.83

Allergy Therapeutics Share Discussion Threads

Showing 3075 to 3100 of 3100 messages
Post New Message
Chat Pages: 124  123  122  121  120  119  118  117  116  115  114  113  >>
DateSubjectAuthorDiscuss
24/8/2015
10:21
Bit of a bloodbath out there today! Think we'll all be a lot poorer on paper by the end of the day! Good buying opportunities!audigger
24/8/2015
07:05
At least we have the Euro strengthening significantly against the pound!!jimmyloser
14/8/2015
12:57
http://www.sneezetoronto.com/birch-allergy-study/jimmyloser
13/8/2015
10:48
cir like to consolidate. You'l never have one product anyway, look at the inhaler mkt for asthma, loads of products with different deliveries. Pain killers, how many different types?celeritas
13/8/2015
08:23
Allergy Therapeutics is also working on expanding its portfolio in other segments of the allergy market, such as those addressing perennial allergens. Thus, the Company is developing Acarovac Quattro, a potential breakthrough treatment for house dust mite allergy. Acarovac Quattro has the potential to replicate the success of the company's Pollinex Quattro product range, which is focussed on the seasonal allergy market and is currently in late stage development in Europe and the US. Am I correct in believing that the above statement from Manuel Llobar puts AGY on a direct and head to head path with Circassia? Is it who gets there first and at what price and ease of use for the consumer. Happy to be correctedjimmyloser
11/8/2015
22:30
28p offer is a lot nearer to 30p than 20p offer Patience.jimmyloser
11/8/2015
21:06
We must surely make a push towards 30 soon!audigger
10/8/2015
14:40
Look at aph go.celeritas
10/8/2015
08:18
http://www.proactiveinvestors.co.uk/companies/news/109804/allergy-therapeutics-team-publish-research-109804.html?utm_source=twitterfeed&utm_medium=twitter Allergy Therapeutics team publish research 07:42 10 Aug 2015 The team has released a paper and published an article based around its ground-breaking research. Allergy Therapeutics team publish research Pictured is microscopic pollen.The team is really understanding the science of allergies. A team from AIM-listed Allergy Therapeutics (LON:AGY) has published research that looks at the “molecular fingerprint” of allergies. Work on the paper and article, which appears in the World Allergy Journal, was led by the company’s chief scientific officer, Dr Murray Skinner. He and his colleagues used what is described as a “novel proteomic approach” to aid their research. Skinner explained: “Our development of proteomic and allergomic concepts as described in this paper underpins our track record in the scientific advancement of our product portfolio, which is an important part of our growth strategy. “These advancements reinforce our focus on patient care and our commitment to invest both in existing and future products to ensure patients receive the treatment they deserve.”qackers
07/8/2015
16:00
Inflamax Research Inc., Birch Study -Recruiting Now! (Sites in Mississauga and Sudbury ON) - This study is investigating a birch tree pollen allergy therapy - Study screening has begun, but all participants must complete a general allergy test before being screening specifically for this study - Study duration ~ 6months; 8 visits in total - Compensation up to $4,100 for successful study completion - Eight visits in totaljimmyloser
06/8/2015
22:55
hTTp://www.bizjournals.com/sanjose/blog/techflash/2015/08/brisbane-peanut-allergy-biotech-raises-160m-in.htmlceleritas
04/8/2015
14:33
Here's another one Shire offering $30b for Baxalta hTTp://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/11782540/Shire-launches-30bn-all-share-approach-for-US-rival-Baxalta.htmlceleritas
04/8/2015
14:29
JL, I agree GW would make a good template.celeritas
04/8/2015
10:28
IMPO, consolidation is off the cards for sometime. GW Pharma went alone in the USA and look at them now. September 21st House dust mite European leader Trials update Ahead of market expectations and etc etc impo/dyorjimmyloser
04/8/2015
10:19
Fresh air above 31p. Also consolidation is rife in this sector, who knows.celeritas
30/7/2015
14:44
Just looking around and I see agy's Italian division has a microbiome division with products out there. I'm amazed agy aren't promoting this more given the interest in microbiome now. Look at 4D, mkt cap close to £600m with no profits at all. hTTp://www.allergytherapeutics.it/pub/LineaProbiotici/Approfondimenti.aspxceleritas
30/7/2015
09:12
Pleasantly surprised and yet again my thanks to Cube Boss for making this look attractive to me at 8.5p Really appreciated.jimmyloser
29/7/2015
17:00
It's time for a rapid 6p jump to take us in to the thirties......volume is still low, so this should pop if a few big buys come on the books....audigger
28/7/2015
17:24
Interesting times. My thoughts are that Manuel didn't need to buy that 50k (he has over 3 million)and did so to indicate just how confident he was with the future. When you have built your business as solidly as these guys have and have gained high credibility ratings from the market you just wouldn't risk it by mis-leading the market when you buy shares. The nomad wouldn't have allowed it either having just lead a £22million fundraising. It will not come as a shock if other Directors also dip their toes in, but in reality they don't need to as we all have the message. I also liked the bullish comments and especially the strong references to house dust mite being next off the line. It will not surprise me at all to see these through the mid thirties by the 22nd of September. impo/dyorjimmyloser
28/7/2015
14:49
Ping! Is an assault on 30p about to happen?audigger
27/7/2015
12:46
Anyone for a breakout?audigger
27/7/2015
07:17
Nice to see That should help underpin the pricejimmyloser
24/7/2015
15:44
Volumes still very low.farmer george
24/7/2015
15:22
That was a very good update yesterday.celeritas
24/7/2015
12:40
I should think so!jimmyloser
Chat Pages: 124  123  122  121  120  119  118  117  116  115  114  113  >>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 150831 18:42